Evidence map›Paper›PMID 38649006›Full record

ArticleInternational journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases2024

Death after cure: Mortality among pulmonary tuberculosis survivors in rural Uganda.

Joseph Baruch Baluku, Brenda Namanda, Sharon Namiiro, Diana Karungi Rwabwera, Gloria Mwesigwa, Catherine Namaara, Bright Twinomugisha, Isabella Nyirazihawe, Edwin Nuwagira, Grace Kansiime and 9 more

Open access · goldAbstract read
In one paragraph

Article in International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. A predictive score for early in-patient tuberculosis mortality: A case-control study.Journal of clinical tuberculosis and other mycobacterial diseases · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 7 institutions in 1 country.

Joseph Baruch BalukuTuberculosis Research Group, Makerere University Lung Institute, Kampala, Uganda; Division of Pulmonology, Kiruddu National Referral Hospital, Kampala, Uganda; Department of Internal Medicine, Mbarara University of Science and Technology, Mbarara, Uganda. Electronic address: bbjoe18@gmail.com.
Brenda NamandaDivision of Pulmonology, Kiruddu National Referral Hospital, Kampala, Uganda.
Sharon NamiiroTuberculosis Research Group, Makerere University Lung Institute, Kampala, Uganda.
Diana Karungi RwabweraDivision of Pulmonology, Kiruddu National Referral Hospital, Kampala, Uganda.
Gloria MwesigwaDepartment of Medicine, Masaka Regional Referral Hospital, Masaka, Uganda.
Catherine NamaaraDepartment of Medicine, Masaka Regional Referral Hospital, Masaka, Uganda.
Bright TwinomugishaDepartment of Medicine, Masaka Regional Referral Hospital, Masaka, Uganda.
Isabella NyirazihaweDepartment of Medicine, Masaka Regional Referral Hospital, Masaka, Uganda.
Edwin NuwagiraDepartment of Internal Medicine, Mbarara University of Science and Technology, Mbarara, Uganda.
Grace KansiimeDepartment of Internal Medicine, Mbarara University of Science and Technology, Mbarara, Uganda.
Enock KizitoLPHS TB Activity, Infectious Disease Institute, Kampala, Uganda.
Mary G Nabukenya-MudiopeLPHS TB Activity, Infectious Disease Institute, Kampala, Uganda.
Moorine Penninah SekaddeNational TB and Leprosy Control Program, Ministry of Health, Kampala, Uganda.
Felix BongominDepartment of Medical Microbiology and Immunology, Faculty of Medicine, Gulu University, Gulu, Uganda.
Joshua SenfukaMonitoring and Evaluation Unit, Uganda Protestant Medical Bureau, Kampala, Uganda.
Ronald OlumSchool of Medicine, Makerere University College of Health Sciences, Kampala, Uganda.
Aggrey ByaruhangaUganda Public Health Fellowship Program, Ministry of Health, Kampala, Uganda.
Ian MunabiSchool of Medicine, Makerere University College of Health Sciences, Kampala, Uganda.
Sarah KiguliSchool of Medicine, Makerere University College of Health Sciences, Kampala, Uganda.
Makerere University · UGMasaka Hospital · UGMbarara University of Science and Technology · UGInfectious Diseases Institute · UGMinistry of Health · UGGulu University · UGUganda Protestant Medical Bureau · UG

Funding

Health Professions Education and training for strengthening the health system and services in UgandaR25TW011213 · FIC · MAKERERE UNIVERSITY COLLEGE OF HEALTH SCIENCES · PI KIGULI, SARAH · 2018 to 2022
$3.4M
FIC NIH HHS R25 TW011213
6 · The paper itself

Abstract

objectivesTo determine the incidence of mortality and its predictors among pulmonary tuberculosis (PTB) survivors treated at a rural Ugandan tertiary hospital.

methodsWe conducted a retrospective chart review of data between 2013 and 2023. We included all people that met the World Health Organisation's definition of tuberculosis cure and traced them or their next of kin to determine vital status (alive/deceased). We estimated the cumulative incidence of mortality per 1000 population, crude all-cause mortality rate per 1000 person-years, and median years of potential life lost for deceased individuals. Using Cox proportional hazard models, we investigated predictors of mortality.

resultsOf 334 PTB survivors enrolled, 38 (11.4%) had died. The cumulative incidence of all-cause mortality was 113.7 per 1000 population, and the crude all-cause mortality rate was 28.5 per 1000 person-years. The median years of potential life lost for deceased individuals was 23.8 years (IQR: 9.6-32.8). Hospitalization (adjusted hazard ratio (aHR): 4.3, 95% CI: 1.1-16.6) and unemployment (aHR: 7.04, 95% CI: 1.5-31.6) at TB treatment initiation predicted mortality.

conclusionPTB survivors experience post high mortality rates after TB cure. Survivors who were hospitalized and unemployed at treatment initiation were more likely to die after cure. Social protection measures and long-term follow-up of previously hospitalized patients could improve the long-term survival of TB survivors.

Indexed as

Rural PopulationSurvivorsTuberculosis, PulmonaryAdolescentAdultAntitubercular AgentsFemaleHospitalizationHumansIncidenceMaleMiddle AgedProportional Hazards ModelsRetrospective StudiesRisk FactorsUgandaAntitubercular AgentsCureHospitalizationSurvivorsTBTreatment completionUnemploymentYears of potential life lost

Identifiers

PMID38649006
PMCPMC11182684
OpenAlexW4394982219

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.